Theravance Biopharma, Inc. - Ordinary Shares (TBPH) earnings
TBPH earnings moved a median of +0.41% by the close. Quarterly and annual TBPH reports and results, each read against the price at its own news timestamp. Back to the TBPH overview →
28 measured TBPH earnings events.
Where these TBPH earnings landedvs 26 measured TBPH earnings reactions
| Middle 50% of TBPH earnings reactions | -1.11% to +1.13% |
|---|---|
| Median reaction (to close) | +0.41% |
| Measured reactions | 26 |
Point-in-time · zero look-ahead
Half of the 26 TBPH earnings events with a measured close landed between -1.11% and +1.13%; 62% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Theravance Biopharma, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.06% | |
| Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | +0.06% | — | |
| Form 10-Q Theravance Biopharma, For: Mar 31 | SEC filing · Form 10-Q | +0.33% | +0.47% | |
| Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | +0.33% | +0.47% | |
| Form 10-K Theravance Biopharma, For: Dec 31 | SEC filing · Form 10-K | -0.03% | +0.14% | |
| Form 10-Q Theravance Biopharma, For: Sep 30 | SEC filing · Form 10-Q | -1.69% | — | |
| Theravance Biopharma, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | +10.02% | +18.82% | |
| Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025 | Press release | +0.35% | -0.35% | |
| Form 10-Q Theravance Biopharma, For: Jun 30 | SEC filing · Form 10-Q | +0.84% | +4.19% | |
| Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | +4.25% | +3.59% | |
| Theravance Biopharma to Report Second Quarter 2025 Financial Results on August 12, 2025 | Press release | +0.46% | +1.00% | |
| Form 10-Q Theravance Biopharma, For: Mar 31 | SEC filing · Form 10-Q | -0.90% | +0.34% | |
| Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | +1.28% | +0.00% | |
| Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025 | Press release | +0.21% | +1.17% | |
| Form 10-K Theravance Biopharma, For: Dec 31 | SEC filing · Form 10-K | -0.31% | -1.14% | |
| Form 10-Q Theravance Biopharma, For: Sep 30 | SEC filing · Form 10-Q | +0.10% | -1.03% | |
| Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value | Press release | +3.17% | +2.22% | |
| Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024 | Press release | +0.52% | +0.70% | |
| Form 10-Q Theravance Biopharma, For: Jun 30 | SEC filing · Form 10-Q | -0.65% | -1.16% | |
| Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | -5.55% | -9.48% | |
| Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024 | Press release | +0.00% | +6.67% | |
| Form 10-Q Theravance Biopharma, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +3.47% | |
| Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | -3.49% | -3.59% | |
| Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024 | Press release | -0.44% | -1.64% | |
| Form 10-K Theravance Biopharma, For: Dec 31 | SEC filing · Form 10-K | -1.38% | -3.19% | |
| Form 10-Q Theravance Biopharma, For: Sep 30 | SEC filing · Form 10-Q | +0.10% | +0.60% | |
| Theravance Biopharma, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | +2.84% | +0.49% | |
| Theravance Biopharma to Report Third Quarter 2023 Financial Results on November 7, 2023 | Press release | -0.66% | -1.43% |
Keep exploring
More TBPH: analyst actions → · SEC filings → · TBPH overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| DBV Technologies S.A. - American Depositary Shares (DBVT) | 327 | -0.15% | 40% |
| Novartis AG (NVS) | 326 | +0.03% | 51% |
| Verona Pharma plc - American Depositary Shares (VRNA) | 325 | -0.03% | 39% |
| Bionano Genomics, Inc. (BNGO) | 321 | -0.94% | 31% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.